How serotonin receptors regulate morphogenic signalling in neurons

Progress in Neurobiology

Volumn 151, Issue , 2017, Pages 35-56

  Wirth, Alexander ^a   Holst, Katrin ^a   Ponimaskin, Evgeni ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Cytoskeleton; Neuronal diseases; Neuronal morphology; Serotonin receptor; Spinogenesis

Indexed keywords

SEROTONIN; SEROTONIN 1 RECEPTOR; SEROTONIN 2 RECEPTOR; SEROTONIN 3 RECEPTOR; SEROTONIN 4 RECEPTOR; SEROTONIN 5 RECEPTOR; SEROTONIN 6 RECEPTOR; SEROTONIN 7 RECEPTOR; SEROTONIN RECEPTOR; SEROTONIN RECEPTOR AFFECTING AGENT;

HUMAN; INTRACELLULAR SIGNALING; NEURITE OUTGROWTH; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEROTONINERGIC NERVE CELL; ANIMAL; BRAIN; CYTOLOGY; DRUG EFFECTS; METABOLISM; NERVE CELL; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; BRAIN; NEURONS; RECEPTORS, SEROTONIN; SEROTONIN AGENTS; SIGNAL TRANSDUCTION;

EID: 85016279101     PISSN: 03010082     EISSN: 18735118     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2016.03.007     Document Type: Review

References (380)

1. Adham, N., Kao, H.T., Schecter, L.E., Bard, J., Olsen, M., Urquhart, D., Durkin, M., Hartig, P.R., Weinshank, R.L., Branchek, T.A., Cloning of another human serotonin receptor (5-HT1F): a fifth 5-HT1 receptor subtype coupled to the inhibition of adenylate cyclase. Proc. Natl. Acad. Sci. U. S. A 90 (1993), 408–412.
2. Albert, P.R., Tiberi, M., Receptor signaling and structure: insights from serotonin-1 receptors. Trends Endocrinol. Metab. TEM 12 (2001), 453–460.
3. Alenina, N., Kikic, D., Todiras, M., Mosienko, V., Qadri, F., Plehm, R., Boyé, P., Vilianovitch, L., Sohr, R., Tenner, K., et al. Growth retardation and altered autonomic control in mice lacking brain serotonin. Proc. Natl. Acad. Sci. U. S. A. 106 (2009), 10332–10337.
4. Alves, S.E., Hoskin, E., Lee, S.J., Brake, W.G., Ferguson, D., Luine, V., Allen, P.B., Greengard, P., McEwen, B.S., Serotonin mediates CA1 spine density but is not crucial for ovarian steroid regulation of synaptic plasticity in the adult rat dorsal hippocampus. Synapse 45 (2002), 143–151.
5. Amano, M., Ito, M., Kimura, K., Fukata, Y., Chihara, K., Nakano, T., Matsuura, Y., Kaibuchi, K., Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J. Biol. Chem. 271 (1996), 20246–20249.
6. Anelli, T., Cardarelli, S., Ori, M., Nardi, I., Biagioni, S., Poiana, G., 5-Hydroxytryptamine 1A and 2B serotonin receptors in neurite outgrowth: involvement of early growth response protein 1. Dev. Neurosci. 35 (2013), 450–460.
7. Ase, A.R., Reader, T.A., Hen, R., Riad, M., Descarries, L., Regional changes in density of serotonin transporter in the brain of 5-HT1A and 5-HT1B knockout mice, and of serotonin innervation in the 5-HT1B knockout. J. Neurochem. 78 (2001), 619–630.
8. Azmitia, E.C., Whitaker-Azmitia, P.M., Development and adult plasticity of serotoninergic neurons and their target cells. Baumgarten, H.G., Göthert, M., (eds.) Serotoninergic Neurons and 5-HT Receptors in the CNS, 2000, Heidelberg, Springer Berlin, 1–39.
9. Azmitia, E.C., Rubinstein, V.J., Strafaci, J.A., Rios, J.C., Whitaker-Azmitia, P.M., 5-HT1A agonist and dexamethasone reversal of para-chloroamphetamine induced loss of MAP-2 and synaptophysin immunoreactivity in adult rat brain. Brain Res. 677 (1995), 181–192.
10. Azmitia, E.C., Gannon, P.J., Kheck, N.M., Whitaker-Azmitia, P.M., Cellular localization of the 5-HT1A receptor in primate brain neurons and glial cells: neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol. 14 (1996), 35–46.
11. Bailey, C.H., Chen, M., Keller, F., Kandel, E.R., Serotonin-mediated endocytosis of apCAM: an early step of learning-related synaptic growth in Aplysia. Science 256 (1992), 645–649.
12. Bailey, A., Luthert, P., Dean, A., Harding, B., Janota, I., Montgomery, M., Rutter, M., Lantos, P., A clinicopathological study of autism. Brain J. Neurol. 121:Pt 5 (1998), 889–905.
13. Baker, M.W., Vohra, M.M., Croll, R.P., Serotonin depletors, 5,7-dihydroxytryptamine and p-chlorophenylalanine: cause sprouting in the CNS of the adult snail. Brain Res. 623 (1993), 311–315.
14. Banasr, M., Hery, M., Printemps, R., Daszuta, A., Serotonin-induced increases in adult cell proliferation and neurogenesis are mediated through different and common 5-HT receptor subtypes in the dentate gyrus and the subventricular zone. Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol. 29 (2004), 450–460.
15. Bard, J.A., Zgombick, J., Adham, N., Vaysse, P., Branchek, T.A., Weinshank, R.L., Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase. J. Biol. Chem. 268 (1993), 23422–23426.
16. Barnes, N.M., Sharp, T., A review of central 5-HT receptors and their function. Neuropharmacology 38 (1999), 1083–1152.
17. Barros, M., Mello, E.L., Maior, R.S., Müller, C.P., de Souza Silva, M.A., Carey, R.J., Huston, J.P., Tomaz, C., Anxiolytic-like effects of the selective 5-HT1A receptor antagonist WAY 100635 in non-human primates. Eur. J. Pharmacol. 482 (2003), 197–203.
18. Barthet, G., Framery, B., Gaven, F., Pellissier, L., Reiter, E., Claeysen, S., Bockaert, J., Dumuis, A., 5-Hydroxytryptamine4 receptor activation of the extracellular signal-regulated kinase pathway depends on src activation but not on G protein or β-Arrestin signaling. Mol. Biol. Cell 18 (2007), 1979–1991.
19. Barthet, G., Carrat, G., Cassier, E., Barker, B., Gaven, F., Pillot, M., Framery, B., Pellissier, L.P., Augier, J., Kang, D.S., et al. Beta-arrestin1 phosphorylation by GRK5 regulates G protein-independent 5-HT4 receptor signalling. EMBO J. 28 (2009), 2706–2718.
20. Bartsch, D., Ghirardi, M., Skehel, P.A., Karl, K.A., Herder, S.P., Chen, M., Bailey, C.H., Kandel, E.R., Aplysia CREB2 represses long-term facilitation: relief of repression converts transient facilitation into long-term functional and structural change. Cell 83 (1995), 979–992.
21. Baudier, J., Cole, R.D., Interactions between the microtubule-associated tau proteins and S100b regulate tau phosphorylation by the Ca2+/calmodulin-dependent protein kinase II. J. Biol. Chem. 263 (1988), 5876–5883.
22. Bayliss, D.A., Umemiya, M., Berger, A.J., Inhibition of N- and P-type calcium currents and the after-hyperpolarization in rat motoneurones by serotonin. J. Physiol. 485:Pt 3 (1995), 635–647.
23. Belelli, D., Balcarek, J.M., Hope, A.G., Peters, J.A., Lambert, J.J., Blackburn, T.P., Cloning and functional expression of a human 5-hydroxytryptamine type 3AS receptor subunit. Mol. Pharmacol. 48 (1995), 1054–1062.
24. Bell, R., Duke, A.A., Gilmore, P.E., Page, D., Bègue, L., Anxiolytic-like effects observed in rats exposed to the elevated zero-maze following treatment with 5-HT2/5-HT3/5-HT4 ligands. Sci. Rep., 4, 2014, 3881.
25. Berg, K.A., Maayani, S., Goldfarb, J., Scaramellini, C., Leff, P., Clarke, W.P., Effector pathway-Dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-Directed trafficking of receptor stimulus. Mol. Pharmacol. 54 (1998), 94–104.
26. Bhatnagar, S., Sun, L.M., Raber, J., Maren, S., Julius, D., Dallman, M.F., Changes in anxiety-related behaviors and hypothalamic-pituitary-adrenal activity in mice lacking the 5-HT-3A receptor. Physiol. Behav. 81 (2004), 545–555.
27. Bhattacharya, A., Kaphzan, H., Alvarez-Dieppa, A.C., Murphy, J.P., Pierre, P., Klann, E., Genetic removal of p70 S6 kinase 1 corrects molecular, synaptic, and behavioral phenotypes in fragile x syndrome mice. Neuron 76 (2012), 325–337.
28. Bickler, P.E., Fahlman, C.S., Moderate increases in intracellular calcium activate neuroprotective signals in hippocampal neurons. Neuroscience 127 (2004), 673–683.
29. Biojone, C., Casarotto, P.C., Joca, S.R., Castrén, E., Interplay between nitric oxide and brain-derived neurotrophic factor in neuronal plasticity. CNS Neurol. Disord. Drug Targets, 2015.
30. Blier, P., Bergeron, R., de Montigny, C., Selective activation of postsynaptic 5-HT1A receptors induces rapid antidepressant response: neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol 16 (1997), 333–338.
31. Bockaert, J., Claeysen, S., Bécamel, C., Dumuis, A., Marin, P., Neuronal 5-HT metabotropic receptors: fine-tuning of their structure signaling, and roles in synaptic modulation. Cell Tissue Res. 326 (2006), 553–572.
32. Bockaert, J., Claeysen, S., Compan, V., Dumuis, A., 5-HT(4) receptors: history, molecular pharmacology and brain functions. Neuropharmacology 55 (2008), 922–931.
33. Boess, F.G., Riemer, C., Bös, M., Bentley, J., Bourson, A., Sleight, A.J., The 5-Hydroxytryptamine6 receptor-Selective radioligand [3H]Ro 63–0563 labels 5-Hydroxytryptamine receptor binding sites in rat and porcine striatum. Mol. Pharmacol. 54 (1998), 577–583.
34. Bonaventure, P., Kelly, L., Aluisio, L., Shelton, J., Lord, B., Galici, R., Miller, K., Atack, J., Lovenberg, T.W., Dugovic, C., Selective blockade of 5-Hydroxytryptamine (5-HT)7 receptors enhances 5-HT transmission, antidepressant-Like behavior, and rapid eye movement sleep suppression induced by citalopram in rodents. J. Pharmacol. Exp. Ther. 321 (2007), 690–698.
35. Bonnin, A., Peng, W., Hewlett, W., Levitt, P., Expression mapping of 5-HT1 serotonin receptor subtypes during fetal and early postnatal mouse forebrain development. Neuroscience 141 (2006), 781–794.
36. Bonnin, A., Torii, M., Wang, L., Rakic, P., Levitt, P., Serotonin modulates the response of embryonic thalamocortical axons to netrin-1. Nat. Neurosci. 10 (2007), 588–597.
37. Bonnin, A., Goeden, N., Chen, K., Wilson, M.L., King, J., Shih, J.C., Blakely, R.D., Deneris, E.S., Levitt, P., A transient placental source of serotonin for the fetal forebrain. Nature 472 (2011), 347–350.
38. Boothman, L., Raley, J., Denk, F., Hirani, E., Sharp, T., In vivo evidence that 5-HT(2C) receptors inhibit 5-HT neuronal activity via a GABAergic mechanism. Br. J. Pharmacol. 149 (2006), 861–869.
39. Bou-Flores, C., Lajard, A.-M., Monteau, R., Maeyer, E.D., Seif, I., Lanoir, J., Hilaire, G., Abnormal phrenic motoneuron activity and morphology in neonatal monoamine oxidase A-deficient transgenic mice: possible role of a serotonin excess. J. Neurosci. 20 (2000), 4646–4656.
40. Brezun, J.-M., Daszuta, A., Serotonin depletion in the adult rat produces differential changes in highly polysialylated form of neural cell adhesion molecule and tenascin-C immunoreactivity. J. Neurosci. Res. 55 (1999), 54–70.
41. Brischoux, F., Chakraborty, S., Brierley, D.I., Ungless, M.A., Phasic excitation of dopamine neurons in ventral VTA by noxious stimuli. Proc. Natl. Acad. Sci. U. S. A. 106 (2009), 4894–4899.
42. Briz, V., Zhu, G., Wang, Y., Liu, Y., Avetisyan, M., Bi, X., Baudry, M., Activity-Dependent rapid local RhoA synthesis is required for hippocampal synaptic plasticity. J. Neurosci. 35 (2015), 2269–2282.
43. Brown, P., Gerfen, C.R., Plasticity within striatal direct pathway neurons following neonatal dopamine depletion is mediated through a novel functional coupling of serotonin 5-HT2 receptors to the ERK 1/2 Map Kinase pathway. J. Comp. Neurol. 498 (2006), 415–430.
44. Bruinvels, A.T., Landwehrmeyer, B., Gustafson, E.L., Durkin, M.M., Mengod, G., Branchek, T.A., Hoyer, D., Palacios, J.M., Localization of 5-HT1B, 5-HT1D alpha, 5-HT1E and 5-HT1F receptor messenger RNA in rodent and primate brain. Neuropharmacology 33 (1994), 367–386.
45. Buhl, A.M., Johnson, N.L., Dhanasekaran, N., Johnson, G.L., Gα12 and Gα13 stimulate rho-dependent stress fiber formation and focal adhesion assembly. J. Biol. Chem. 270 (1995), 24631–24634.
46. Burnet, P.W., Eastwood, S.L., Lacey, K., Harrison, P.J., The distribution of 5-HT1A and 5-HT2A receptor mRNA in human brain. Brain Res. 676 (1995), 157–168.
47. Burnet, P.W., Eastwood, S.L., Harrison, P.J., 5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia. Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol. 15 (1996), 442–455.
48. Cai, D., Shen, Y., De Bellard, M., Tang, S., Filbin, M.T., Prior exposure to neurotrophins blocks inhibition of axonal regeneration by MAG and myelin via a cAMP-dependent mechanism. Neuron 22 (1999), 89–101.
49. Canese, R., Zoratto, F., Altabella, L., Porcari, P., Mercurio, L., de Pasquale, F., Butti, E., Martino, G., Lacivita, E., Leopoldo, M., et al. Persistent modification of forebrain networks and metabolism in rats following adolescent exposure to a 5-HT7 receptor agonist. Psychopharmacology (Berl.) 232 (2015), 75–89.
50. Cardenas, C.G., Del Mar, L.P., Scroggs, R.S., Two parallel signaling pathways couple 5HT1A receptors to N- and L-type calcium channels in C-like rat dorsal root ganglion cells. J. Neurophysiol. 77 (1997), 3284–3296.
51. Carper, R.A., Courchesne, E., Localized enlargement of the frontal cortex in early autism. Biol. Psychiatry 57 (2005), 126–133.
52. Carson, M.J., Thomas, E.A., Danielson, P.E., Sutcliffe, J.G., The 5HT5A serotonin receptor is expressed predominantly by astrocytes in which it inhibits cAMP accumulation: a mechanism for neuronal suppression of reactive astrocytes. Glia 17 (1996), 317–326.
53. Casanova, M.F., Buxhoeveden, D.P., Switala, A.E., Roy, E., Minicolumnar pathology in autism. Neurology 58 (2002), 428–432.
54. Cerrito, F., Raiteri, M., Serotonin release is modulated by presynaptic autoreceptors. Eur. J. Pharmacol. 57 (1979), 427–430.
55. Chameau, P., van Hooft, J.A., Serotonin 5-HT3 receptors in the central nervous system. Cell Tissue Res. 326 (2006), 573–581.
56. Chameau, P., Inta, D., Vitalis, T., Monyer, H., Wadman, W.J., van Hooft, J.A., The N-terminal region of reelin regulates postnatal dendritic maturation of cortical pyramidal neurons. Proc. Natl. Acad. Sci. U. S. A. 106 (2009), 7227–7232.
57. Cheng, A., Wan, R., Yang, J.-L., Kamimura, N., Son, T.G., Ouyang, X., Luo, Y., Okun, E., Mattson, M.P., Involvement of PGC-1α in the formation and maintenance of neuronal dendritic spines. Nat. Commun., 3, 2012, 1250.
58. Cho, S., Hu, Y., Activation of 5-HT4 receptors inhibits secretion of β-amyloid peptides and increases neuronal survival. Exp. Neurol. 203 (2007), 274–278.
59. Choi, Y.-B., Li, H.-L., Kassabov, S.R., Jin, I., Puthanveettil, S.V., Karl, K.A., Lu, Y., Kim, J.-H., Bailey, C.H., Kandel, E.R., Neurexin-Neuroligin trans-Synaptic interaction mediates learning-Related synaptic remodeling and long-Term facilitation in aplysia. Neuron 70 (2011), 468–481.
60. Ciranna, L., Catania, M.V., 5-HT7 receptors as modulators of neuronal excitability, synaptic transmission and plasticity: physiological role and possible implications in autism spectrum disorders. Front. Cell. Neurosci., 8, 2014, 250.
61. Citri, A., Malenka, R.C., Synaptic plasticity: multiple forms, functions, and mechanisms. Neuropsychopharmacology 33 (2008), 18–41.
62. Codony, X., Vela, J.M., Ramírez, M.J., 5-HT6 receptor and cognition. Curr. Opin. Pharmacol. 11 (2011), 94–100.
63. Collins, F., Schmidt, M.F., Guthrie, P.B., Kater, S.B., Sustained increase in intracellular calcium promotes neuronal survival. J. Neurosci. 11 (1991), 2582–2587.
64. Conn, P.J., Sanders-Bush, E., Selective 5ht-2 antagonists inhibit serotonin stimulated phosphatidylinositol metabolism in cerebral cortex. Neuropharmacology 23 (1984), 993–996.
65. Costa, L., Spatuzza, M., D'Antoni, S., Bonaccorso, C.M., Trovato, C., Musumeci, S.A., Leopoldo, M., Lacivita, E., Catania, M.V., Ciranna, L., Activation of 5-HT7 serotonin receptors reverses metabotropic glutamate receptor-Mediated synaptic plasticity in wild-Type and fmr1 knockout mice, a model of fragile x syndrome. Biol. Psychiatry 72 (2012), 924–933.
66. Costa, L., Sardone, L.M., Lacivita, E., Leopoldo, M., Ciranna, L., Novel agonists for serotonin 5-HT7 receptors reverse metabotropic glutamate receptor-mediated long-term depression in the hippocampus of wild-type and Fmr1 KO mice, a model of Fragile X Syndrome. Front. Behav. Neurosci., 9, 2015, 65.
67. Creed, M.C., Ntamati, N.R., Tan, K.R., VTA GABA neurons modulate specific learning behaviors through the control of dopamine and cholinergic systems. Front. Behav. Neurosci., 8, 2014.
68. Crespo, I., Santos, A., Valassi, E., Pires, P., Webb, S.M., Resmini, E., Impaired decision making and delayed memory are related with anxiety and depressive symptoms in acromegaly. Endocrine, 2015, 1–8.
69. Curtin, P.C.P., Medan, V., Neumeister, H., Bronson, D.R., Preuss, T., The 5-HT5A receptor regulates excitability in the auditory startle circuit: functional implications for sensorimotor gating. J. Neurosci. Off. J. Soc. Neurosci. 33 (2013), 10011–10020.
70. Cussac, D., Newman-Tancredi, A., Duqueyroix, D., Pasteau, V., Millan, M.J., Differential activation of Gq/11 and Gi(3) proteins at 5-hydroxytryptamine(2C) receptors revealed by antibody capture assays: influence of receptor reserve and relationship to agonist-directed trafficking. Mol. Pharmacol. 62 (2002), 578–589.
71. Dahlstroem, A., Fuxe, K., Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain stem neurons. Acta Physiol. Scand. Suppl. 232:Suppl (1964), 1–55.
72. Daubert, E.A., Condron, B.G., Serotonin: a regulator of neuronal morphology and circuitry. Trends Neurosci. 33 (2010), 424–434.
73. Davies, P.A., Pistis, M., Hanna, M.C., Peters, J.A., Lambert, J.J., Hales, T.G., Kirkness, E.F., The 5-HT3B subunit is a major determinant of serotonin-receptor function. Nature 397 (1999), 359–363.
74. Dawson, L.A., Nguyen, H.Q., Li, P., In vivo effects of the 5-HT6 antagonist SB-271046 on striatal and frontal cortex extracellular concentrations of noradrenaline dopamine, 5-HT, glutamate and aspartate. Br. J. Pharmacol. 130 (2000), 23–26.
75. Dawson, L.A., Nguyen, H.Q., Li, P., The 5-HT6 receptor antagonist SB-271046 selectively enhances excitatory neurotransmission in the rat frontal cortex and hippocampus. Neuropsychopharmacology 25 (2001), 662–668.
76. Deecher, D.C., Wilcox, B.D., Dave, V., Rossman, P.A., Kimelberg, H.K., Detection of 5-hydroxytryptamine2 receptors by radioligand binding, northern blot analysis, and Ca2+ responses in rat primary astrocyte cultures. J. Neurosci. Res. 35 (1993), 246–256.
77. Della Rocca, G.J., Mukhin, Y.V., Garnovskaya, M.N., Daaka, Y., Clark, G.J., Luttrell, L.M., Lefkowitz, R.J., Raymond, J.R., Serotonin 5-HT1A receptor-mediated Erk activation requires calcium/calmodulin-dependent receptor endocytosis. J. Biol. Chem. 274 (1999), 4749–4753.
78. Deng, W., Obrocka, M., Fischer, I., Prockop, D.J., In vitro differentiation of human marrow stromal cells into early progenitors of neural cells by conditions that increase intracellular cyclic AMP. Biochem. Biophys. Res. Commun. 282 (2001), 148–152.
79. Di Giovanni, G., De Deurwaerdère, P., New therapeutic opportunities for 5-HT2C receptor ligands in neuropsychiatric disorders. Pharmacol. Ther. 157 (2016), 125–162.
80. Di Giovanni, G., Serotonin in the pathophysiology and treatment of CNS disorders. Exp. Brain Res. 230 (2013), 371–373.
81. Di Matteo, V., Di Giovanni, G., Di Mascio, M., Esposito, E., Biochemical and electrophysiological evidence that RO 60-0175 inhibits mesolimbic dopaminergic function through serotonin(2C) receptors. Brain Res. 865 (2000), 85–90.
82. Diefenbach, T.J., Sloley, B.D., Goldberg, J.I., Neurite branch development of an identified serotonergic neuron from embryonic helisoma: evidence for autoregulation by serotonin. Dev. Biol. 167 (1995), 282–293.
83. Dityatev, A., Schachner, M., Extracellular matrix molecules and synaptic plasticity. Nat. Rev. Neurosci. 4 (2003), 456–468.
84. Dityatev, A., Schachner, M., Sonderegger, P., The dual role of the extracellular matrix in synaptic plasticity and homeostasis. Nat. Rev. Neurosci. 11 (2010), 735–746.
85. Dogrul, A., Seyrek, M., Systemic morphine produce antinociception mediated by spinal 5-HT7: but not 5-HT1A and 5-HT2 receptors in the spinal cord. Br. J. Pharmacol. 149 (2006), 498–505.
86. Donaldson, Z.R., Piel, D.A., Santos, T.L., Richardson-Jones, J., Leonardo, E.D., Beck, S.G., Champagne, F.A., Hen, R., Developmental effects of serotonin 1A autoreceptors on anxiety and social behavior. Neuropsychopharmacology 39 (2014), 291–302.
87. Donovan, F.M., Pike, C.J., Cotman, C.W., Cunningham, D.D., Thrombin induces apoptosis in cultured neurons and astrocytes via a pathway requiring tyrosine kinase and RhoA activities. J. Neurosci. Off. J. Soc. Neurosci. 17 (1997), 5316–5326.
88. Dooley, A.E., Pappas, I.S., Parnavelas, J.G., Serotonin promotes the survival of cortical glutamatergic neurons in vitro. Exp. Neurol. 148 (1997), 205–214.
89. Drevets, W.C., Frank, E., Price, J.C., Kupfer, D.J., Greer, P.J., Mathis, C., Serotonin type-1A receptor imaging in depression. Nucl. Med. Biol. 27 (2000), 499–507.
90. Dudok, J.J., Groffen, A.J.A., Witter, M.P., Voorn, P., Verhage, M., Chronic activation of the 5-HT2 receptor reduces 5-HT neurite density as studied in organotypic slice cultures. Brain Res. 1302 (2009), 1–9.
91. Duhr, F., Déléris, P., Raynaud, F., Séveno, M., Morisset-Lopez, S., Mannoury la Cour, C., Millan, M.J., Bockaert, J., Marin, P., Chaumont-Dubel, S., Cdk5 induces constitutive activation of 5-HT6 receptors to promote neurite growth. Nat. Chem. Biol. 10 (2014), 590–597.
92. Dumuis, A., Bouhelal, R., Sebben, M., Cory, R., Bockaert, J., A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system. Mol. Pharmacol. 34 (1988), 880–887.
93. Duncan, M.J., Jennes, L., Jefferson, J.B., Brownfield, M.S., Localization of serotonin5A receptors in discrete regions of the circadian timing system in the Syrian hamster. Brain Res. 869 (2000), 178–185.
94. Durig, J., Hornung, J.-P., Neonatal serotonin depletion affects developing and mature mouse cortical neurons. Neuroreport 11 (2000), 833–837.
95. Duxon, M.S., Flanigan, T.P., Reavley, A.C., Baxter, G.S., Blackburn, T.P., Fone, K.C., Evidence for expression of the 5-hydroxytryptamine-2B receptor protein in the rat central nervous system. Neuroscience 76 (1997), 323–329.
96. Engel, M., Smidt, M.P., van Hooft, J.A., The serotonin 5-HT3 receptor: a novel neurodevelopmental target. Front. Cell. Neurosci., 7, 2013, 76.
97. Erlander, M.G., Lovenberg, T.W., Baron, B.M., de Lecea, L., Danielson, P.E., Racke, M., Slone, A.L., Siegel, B.W., Foye, P.E., Cannon, K., Two members of a distinct subfamily of 5-hydroxytryptamine receptors differentially expressed in rat brain. Proc. Natl. Acad. Sci. U. S. A. 90 (1993), 3452–3456.
98. Erspamer, V., Asero, B., Identification of enteramine, the specific hormone of the enterochromaffin cell system, as 5-Hydroxytryptamine. Nature 169 (1952), 800–801.
99. Felder, C.C., Kanterman, R.Y., Ma, A.L., Axelrod, J., Serotonin stimulates phospholipase A2 and the release of arachidonic acid in hippocampal neurons by a type 2 serotonin receptor that is independent of inositolphospholipid hydrolysis. Proc. Natl. Acad. Sci. U. S. A. 87 (1990), 2187–2191.
100. Fidalgo, S., Ivanov, D.K., Wood, S.H., Serotonin: from top to bottom. Biogerontology 14 (2013), 21–45.
101. Francken, B.J., Jurzak, M., Vanhauwe, J.F., Luyten, W.H., Leysen, J.E., The human 5-ht5A receptor couples to Gi/Go proteins and inhibits adenylate cyclase in HEK 293 cells. Eur. J. Pharmacol. 361 (1998), 299–309.
102. Franke, B., Bayatti, N., Engele, J., Neurotrophins require distinct extracellular signals to promote the survival of CNS neurons in vitro. Exp. Neurol. 165 (2000), 125–135.
103. Frazer, S., Otomo, K., Dayer, A., Early-life serotonin dysregulation affects the migration and positioning of cortical interneuron subtypes. Transl. Psychiatry, 5, 2015, e644.
104. Frey, U., Huang, Y.Y., Kandel, E.R., Effects of cAMP simulate a late stage of LTP in hippocampal CA1 neurons. Science 260 (1993), 1661–1664.
105. Fricker, A.D., Rios, C., Devi, L.A., Gomes, I., Serotonin receptor activation leads to neurite outgrowth and neuronal survival. Mol. Brain Res 138 (2005), 228–235.
106. Gérard, C., Martres, M.-P., Lefèvre, K., Miquel, M.-C., Vergé, D., Lanfumey, L., Doucet, E., Hamon, M., El Mestikawy, S., Immuno-localization of serotonin 5-HT6 receptor-like material in the rat central nervous system. Brain Res. 746 (1997), 207–219.
107. Gaddum, J.H., Picarelli, Z.P., Two kinds of tryptamine receptor. Br. J. Pharmacol. Chemother. 12 (1957), 323–328.
108. Gellynck, E., Heyninck, K., Andressen, K.W., Haegeman, G., Levy, F.O., Vanhoenacker, P., Van Craenenbroeck, K., The serotonin 5-HT7 receptors: two decades of research. Exp. Brain Res. 230 (2013), 555–568.
109. Gerhardt, C.C., van Heerikhuizen, H., Functional characteristics of heterologously expressed 5-HT receptors. Eur. J. Pharmacol. 334 (1997), 1–23.
110. Giannoni, P., Gaven, F., de Bundel, D., Baranger, K., Marchetti-Gauthier, E., Roman, F.S., Valjent, E., Marin, P., Bockaert, J., Rivera, S., et al. Early administration of RS 67333, a specific 5-HT4 receptor agonist, prevents amyloidogenesis and behavioral deficits in the 5XFAD mouse model of Alzheimer's disease. Front. Aging Neurosci., 5, 2013, 96.
111. Gobert, A., Millan, M.J., Serotonin (5-HT)2A receptor activation enhances dialysate levels of dopamine and noradrenaline, but not 5-HT, in the frontal cortex of freely-moving rats. Neuropharmacology 38 (1999), 315–317.
112. Goldberg, J.I., Mills, L.R., Kater, S.B., Novel effects of serotonin on neurite outgrowth in neurons cultured from embryos of Helisoma trivolvis. J. Neurobiol. 22 (1991), 182–194.
113. Gonzalez, R., Chávez-Pascacio, K., Meneses, A., Role of 5-HT5A receptors in the consolidation of memory. Behav. Brain Res. 252 (2013), 246–251.
114. Goodfellow, N.M., Bailey, C.D.C., Lambe, E.K., The native serotonin 5-HT5A receptor: electrophysiological characterization in rodent cortex and 5-HT1A-Mediated compensatory plasticity in the knock-Out mouse. J. Neurosci. 32 (2012), 5804–5809.
115. Graf, M., Jakus, R., Kantor, S., Levay, G., Bagdy, G., Selective 5-HT1A and 5-HT7 antagonists decrease epileptic activity in the WAG/Rij rat model of absence epilepsy. Neurosci. Lett. 359 (2004), 45–48.
116. Grailhe, R., Waeber, C., Dulawa, S.C., Hornung, J.P., Zhuang, X., Brunner, D., Geyer, M.A., Hen, R., Increased exploratory activity and altered response to LSD in mice lacking the 5-HT5A receptor. Neuron 22 (1999), 581–591.
117. Grimes, M.T., Powell, M., Gutierrez, S.M., Darby-King, A., Harley, C.W., McLean, J.H., Epac activation initiates associative odor preference memories in the rat pup. Learn. Mem. 22 (2015), 74–82.
118. Gross, C., Zhuang, X., Stark, K., Ramboz, S., Oosting, R., Kirby, L., Santarelli, L., Beck, S., Hen, R., Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult. Nature 416 (2002), 396–400.
119. Gruart, A., Benito, E., Delgado-García, J.M., Barco, A., Enhanced cAMP response element-binding protein activity increases neuronal excitability, hippocampal long-term potentiation, and classical eyeblink conditioning in alert behaving mice. J. Neurosci. Off. J. Soc. Neurosci. 32 (2012), 17431–17441.
120. Guadiana, S.M., Semple-Rowland, S., Daroszewski, D., Madorsky, I., Breunig, J.J., Mykytyn, K., Sarkisian, M.R., Arborization of dendrites by developing neocortical neurons is dependent on primary cilia and type 3 adenylyl cyclase. J. Neurosci. 33 (2013), 2626–2638.
121. Guo, W., Qian, L., Zhang, J., Zhang, W., Morrison, A., Hayes, P., Wilson, S., Chen, T., Zhao, J., Sirt1 overexpression in neurons promotes neurite outgrowth and cell survival through inhibition of the mTOR signaling. J. Neurosci. Res. 89 (2011), 1723–1736.
122. Guscott, M., Bristow, L.J., Hadingham, K., Rosahl, T.W., Beer, M.S., Stanton, J.A., Bromidge, F., Owens, A.P., Huscroft, I., Myers, J., et al. Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest therapeutic potential in depression. Neuropharmacology 48 (2005), 492–502.
123. 4 receptor levels in hippocampus correlates inversely with memory test performance in humans: the 5-HT4 receptor and memory functions. Hum. Brain Mapp. 34 (2013), 3066–3074.
124. Hajszan, T., Dow, A., Warner-Schmidt, J.L., Szigeti-Buck, K., Sallam, N.L., Parducz, A., Leranth, C., Duman, R.S., Remodeling of hippocampal spine synapses in the rat learned helplessness model of depression. Biol. Psychiatry 65 (2009), 392–400.
125. Haleem, D.J., 5-HT1A receptor-dependent control of nigrostriatal dopamine neurotransmission in the pharmacotherapy of Parkinson's disease and schizophrenia. Behav. Pharmacol. 26 (2015), 45–58.
126. Hall, A., Rho GTPases and the actin cytoskeleton. Science 279 (1998), 509–514.
127. Hamon, M., Gozlan, H., el Mestikawy, S., Emerit, M.B., Bolaños, F., Schechter, L., The central 5-HT1A receptors: pharmacological, biochemical, functional, and regulatory properties. Ann. N. Y. Acad. Sci. 600 (1990), 114–129 (discussion 129–131).
128. Han, L.-N., Zhang, L., Li, L.-B., Sun, Y.-N., Wang, Y., Chen, L., Guo, Y., Zhang, Y.-M., Zhang, Q.-J., Liu, J., Activation of serotonin(2C) receptors in the lateral habenular nucleus increases the expression of depression-related behaviors in the hemiparkinsonian rat. Neuropharmacology 93 (2015), 68–79.
129. Haring, J.H., Yan, W., Dentate granule cell function after neonatal treatment with parachloroamphetamine or 5,7-dihydroxytryptamine. Dev. Brain Res. 114 (1999), 269–272.
130. Hay-Schmidt, A., The evolution of the serotonergic nervous system. Proc. R. Soc. B Biol. Sci. 267 (2000), 1071–1079.
131. Hayashi, T., Ohtani, A., Onuki, F., Natsume, M., Li, F., Satou, T., Yoshikawa, M., Senzaki, K., Shiga, T., Roles of serotonin 5-HT3 receptor in the formation of dendrites and axons in the rat cerebral cortex: an in vitro study. Neurosci. Res. 66 (2010), 22–29.
132. Haydon, P.G., McCobb, D.P., Kater, S.B., Serotonin selectively inhibits growth cone motility and synaptogenesis of specific identified neurons. Science 226 (1984), 561–564.
133. Hedlund, P.B., Sutcliffe, J.G., Functional, molecular and pharmacological advances in 5-HT7 receptor research. Trends Pharmacol. Sci. 25 (2004), 481–486.
134. Hedlund, P.B., Huitron-Resendiz, S., Henriksen, S.J., Sutcliffe, J.G., 5-HT7 receptor inhibition and inactivation induce antidepressantlike behavior and sleep pattern. Biol. Psychiatry 58 (2005), 831–837.
135. Heidmann, D.E.A., Metcalf, M.A., Kohen, R., Hamblin, M.W., Four 5-Hydroxytryptamine7 (5-HT7) receptor isoforms in human and rat produced by alternative splicing: species differences due to altered intron-Exon organization. J. Neurochem. 68 (1997), 1372–1381.
136. Heine, M., Ponimaskin, E., Bickmeyer, U., Richter, D.W., 5-HT-receptor-induced changes of the intracellular cAMP level monitored by a hyperpolarization-activated cation channel. Pflüg. Arch. Eur. J. Physiol. 443 (2002), 418–426.
137. Heisler, L.K., Chu, H.-M., Brennan, T.J., Danao, J.A., Bajwa, P., Parsons, L.H., Tecott, L.H., Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice. Proc. Natl. Acad. Sci. 95 (1998), 15049–15054.
138. Hoeffer, C.A., Klann, E., mTOR signaling: at the crossroads of plasticity, memory, and disease. Trends Neurosci., 33, 2010, 67.
139. Homma, K., Kitamura, Y., Ogawa, H., Oka, K., Serotonin induces the increase in intracellular Ca2+ that enhances neurite outgrowth in PC12 cells via activation of 5-HT3 receptors and voltage-gated calcium channels. J. Neurosci. Res. 84 (2006), 316–325.
140. Hoyer, D., Middlemiss, D.N., Species differences in the pharmacology of terminal 5-HT autoreceptors in mammalian brain. Trends Pharmacol. Sci. 10 (1989), 130–132.
141. Hoyer, D., Schoeffter, P., Waeber, C., Palacios, J.M., Serotonin 5-HT1D receptors. Ann. N. Y. Acad. Sci. 600 (1990), 168–181 discussion 181–182.
142. Huang, J., Strafaci, J.A., Azmitia, E.C., 5-HT1A receptor agonist reverses adrenalectomy-induced loss of granule neuronal morphology in the rat dentate gyrus. Neurochem. Res. 22 (1997), 1329–1337.
143. Huber, K.M., Gallagher, S.M., Warren, S.T., Bear, M.F., Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proc. Natl. Acad. Sci. U. S. A. 99 (2002), 7746–7750.
144. Hurlemann, R., Boy, C., Meyer, P.T., Scherk, H., Wagner, M., Herzog, H., Coenen, H.H., Vogeley, K., Falkai, P., Zilles, K., et al. Decreased prefrontal 5-HT2A receptor binding in subjects at enhanced risk for schizophrenia. Anat. Embryol. (Berl.) 210 (2005), 519–523.
145. Hurley, P.T., McMahon, R.A., Fanning, P., O'Boyle, K.M., Rogers, M., Martin, F., Functional coupling of a recombinant Human 5-HT5A receptor to G-proteins in HEK-293 cells. Br. J. Pharmacol. 124 (1998), 1238–1244.
146. Hurren, K.M., Berlie, H.D., Lorcaserin: an investigational serotonin 2C agonist for weight loss. Am. J. Health-Syst. Pharm. AJHP Off. J. Am. Soc. Health-Syst. Pharm. 68 (2011), 2029–2037.
147. Ibata, K., Sun, Q., Turrigiano, G.G., Rapid synaptic scaling induced by changes in postsynaptic firing. Neuron 57 (2008), 819–826.
148. Idova, G.V., Jur'ev, D.V., Zhukova, E.N., Kuznetsova, S.M., Immune response during activation of pre- and postsynaptic serotonin 5-HT(1A) receptors in C57Bl/6: J mice at various stages of a depression-like state. Bull. Exp. Biol. Med. 151 (2011), 356–358.
149. Igarashi, M., Li, W.W., Sudo, Y., Fishman, M.C., Ligand-induced growth cone collapse: amplification and blockade by variant GAP-43 peptides. J. Neurosci. 15 (1995), 5660–5667.
150. Ishizuka, T., Goshima, H., Ozawa, A., Watanabe, Y., Stimulation of 5-HT4 receptor enhances differentiation of mouse induced pluripotent stem cells into neural progenitor cells. Clin. Exp. Pharmacol. Physiol. 41 (2014), 345–350.
151. Jacobshagen, M., Niquille, M., Chaumont-Dubel, S., Marin, P., Dayer, A., The serotonin 6 receptor controls neuronal migration during corticogenesis via a ligand-independent Cdk5-dependent mechanism. Development 141 (2014), 3370–3377.
152. Jakeman, L.B., To, Z.P., Eglen, R.M., Wong, E.H., Bonhaus, D.W., Quantitative autoradiography of 5-HT4 receptors in brains of three species using two structurally distinct radioligands, [3H]GR113808 and [3H]BIMU-1. Neuropharmacology 33 (1994), 1027–1038.
153. Jaworski, J., Spangler, S., Seeburg, D.P., Hoogenraad, C.C., Sheng, M., Control of dendritic arborization by the phosphoinositide-3′-Kinase–Akt–Mammalian target of rapamycin pathway. J. Neurosci. 25 (2005), 11300–11312.
154. Jeong, H.J., Han, S.H., Min, B.I., Cho, Y.W., 5-HT1A receptor-mediated activation of G-protein-gated inwardly rectifying K+ current in rat periaqueductal gray neurons. Neuropharmacology 41 (2001), 175–185.
155. Jha, S., Rajendran, R., Fernandes, K.A., Vaidya, V.A., 5-HT2A/2C receptor blockade regulates progenitor cell proliferation in the adult rat hippocampus. Neurosci. Lett. 441 (2008), 210–214.
156. Johnston, A., McBain, C.J., Fisahn, A., 5-Hydroxytryptamine1A receptor-activation hyperpolarizes pyramidal cells and suppresses hippocampal gamma oscillations via Kir3 channel activation. J. Physiol. 592 (2014), 4187–4199.
157. Jori, F.P., Napolitano, M.A., Melone, M.A.B., Cipollaro, M., Cascino, A., Altucci, L., Peluso, G., Giordano, A., Galderisi, U., Molecular pathways involved in neural in vitro differentiation of marrow stromal stem cells. J. Cell. Biochem. 94 (2005), 645–655.
158. Kao, H.-T., Song, H., Porton, B., Ming, G., Hoh, J., Abraham, M., Czernik, A.J., Pieribone, V.A., Poo, M., Greengard, P., A protein kinase A-dependent molecular switch in synapsins regulates neurite outgrowth. Nat. Neurosci. 5 (2002), 431–437.
159. Kassai, F., Schlumberger, C., Kedves, R., Pietraszek, M., Jatzke, C., Lendvai, B., Gyertyán, I., Danysz, W., Effect of 5-HT5A antagonists in animal models of schizophrenia: anxiety and depression. Behav. Pharmacol. 23 (2012), 397–406.
160. Katsurabayashi, S., Kubota, H., Tokutomi, N., Akaike, N., A distinct distribution of functional presynaptic 5-HT receptor subtypes on GABAergic nerve terminals projecting to single hippocampal CA1 pyramidal neurons. Neuropharmacology 44 (2003), 1022–1030.
161. Kelley, S.P., Bratt, A.M., Hodge, C.W., Targeted gene deletion of the 5-HT3A receptor subunit produces an anxiolytic phenotype in mice. Eur. J. Pharmacol. 461 (2003), 19–25.
162. †. Biochemistry (Mosc.) 46 (2007), 6677–6687.
163. Kennett, G.A., Bailey, F., Piper, D.C., Blackburn, T.P., Effect of SB 200646A a 5-HT2C/5-HT2B receptor antagonist, in two conflict models of anxiety. Psychopharmacology (Berl.) 118 (1995), 178–182.
164. Khan, M.M., Dhandapani, K.M., Zhang, Q.-G., Brann, D.W., Estrogen regulation of spine density and excitatory synapses in rat prefrontal and somatosensory cerebral cortex. Steroids 78 (2013), 614–623.
165. Kienlen Campard, P., Crochemore, C., René, F., Monnier, D., Koch, B., Loeffler, J.P., PACAP type I receptor activation promotes cerebellar neuron survival through the cAMP/PKA signaling pathway. DNA Cell Biol. 16 (1997), 323–333.
166. Klemenhagen, K.C., Gordon, J.A., David, D.J., Hen, R., Gross, C.T., Increased fear response to contextual cues in mice lacking the 5-HT1A receptor: neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol. 31 (2006), 101–111.
167. Kobe, F., Guseva, D., Jensen, T.P., Wirth, A., Renner, U., Hess, D., Muller, M., Medrihan, L., Zhang, W., Zhang, M., et al. 5-HT7R/G12 signaling regulates neuronal morphology and function in an age-Dependent manner. J. neurosci. off. J. Soc. Neurosci. 32 (2012), 2915–2930.
168. Koert, C.E., Spencer, G.E., Minnen, J., van Li, K.W., Geraerts, W.P.M., Syed, N.I., Smit, A.B., van Kesteren, R.E., Functional implications of neurotransmitter expression during axonal regeneration: serotonin, but not peptides, Auto-Regulate axon growth of an identified central neuron. J. Neurosci. 21 (2001), 5597–5606.
169. Kofuji, P., Davidson, N., Lester, H.A., Evidence that neuronal G-protein-gated inwardly rectifying K+ channels are activated by G beta gamma subunits and function as heteromultimers. Proc. Natl. Acad. Sci. U. S. A 92 (1995), 6542–6546.
170. Kojic, L., Dyck, R.H., Gu, Q., Douglas, R.M., Matsubara, J., Cynader, M.S., Columnar distribution of serotonin-dependent plasticity within kitten striate cortex. Proc. Natl. Acad. Sci. U. S. A. 97 (2000), 1841–1844.
171. Kondo, M., Nakamura, Y., Ishida, Y., Shimada, S., The 5-HT3 receptor is essential for exercise-induced hippocampal neurogenesis and antidepressant effects. Mol. Psychiatry 20 (2015), 1428–1437.
172. Kondoh, M., Shiga, T., Okado, N., Regulation of dendrite formation of Purkinje cells by serotonin through serotonin1A and serotonin2A receptors in culture. Neurosci. Res. 48 (2004), 101–109.
173. Korkotian, E., Segal, M., Spike-associated fast contraction of dendritic spines in cultured hippocampal neurons. Neuron 30 (2001), 751–758.
174. Koyama, S., Matsumoto, N., Murakami, N., Kubo, C., Nabekura, J., Akaike, N., Role of presynaptic 5-HT1A and 5-HT3 receptors in modulation of synaptic GABA transmission in dissociated rat basolateral amygdala neurons. Life Sci. 72 (2002), 375–387.
175. Kulla, A., Manahan-Vaughan, D., Modulation by serotonin 5-HT4 receptors of long-term potentiation and depotentiation in the dentate gyrus of freely moving rats. Cereb. Cortex 12 (2002), 150–162.
176. Kumar, V., Zhang, M.-X., Swank, M.W., Kunz, J., Wu, G.-Y., Regulation of dendritic morphogenesis by Ras–PI3K–Akt–mTOR and Ras–MAPK signaling pathways. J. Neurosci. 25 (2005), 11288–11299.
177. Kurrasch-Orbaugh, D.M., Parrish, J.C., Watts, V.J., Nichols, D.E., A complex signaling cascade links the serotonin2A receptor to phospholipase A2 activation: the involvement of MAP kinases. J. Neurochem. 86 (2003), 980–991.
178. Kutuzov, M.A., Andreeva, A.V., Voyno-Yasenetskaya, T.A., Regulation of apoptosis signal-regulating kinase 1 degradation by G alpha13. FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol. 21 (2007), 3727–3736.
179. Kvachnina, E., Liu, G., Dityatev, A., Renner, U., Dumuis, A., Richter, D.W., Dityateva, G., Schachner, M., Voyno-Yasenetskaya, T.A., Ponimaskin, E.G., 5-HT7 receptor is coupled to Gα subunits of heterotrimeric G12-Protein to regulate gene transcription and neuronal morphology. J. Neurosci. 25 (2005), 7821–7830.
180. Kvachnina, E., 5-HT7 receptor is coupled to G subunits of heterotrimeric G12-Protein to regulate gene transcription and neuronal morphology. J. Neurosci. 25 (2005), 7821–7830.
181. López-Figueroa, A.L., Norton, C.S., López-Figueroa, M.O., Armellini-Dodel, D., Burke, S., Akil, H., López, J.F., Watson, S.J., Serotonin 5-HT1A, 5-HT1B, and 5-HT2A receptor mRNA expression in subjects with major depression, bipolar disorder, and schizophrenia. Biol. Psychiatry 55 (2004), 225–233.
182. López-Giménez, J.F., Mengod, G., Palacios, J.M., Vilaró, M.T., Selective visualization of rat brain 5-HT2A receptors by autoradiography with [3H]MDL 100,907. Naunyn. Schmiedebergs Arch. Pharmacol. 356 (1997), 446–454.
183. Lamirault, L., Simon, H., Enhancement of place and object recognition memory in young adult and old rats by RS 67333, a partial agonist of 5-HT4 receptors. Neuropharmacology 41 (2001), 844–853.
184. Lamirault, L., Guillou, C., Thal, C., Simon, H., Combined treatment with galanthaminium bromide, a new cholinesterase inhibitor, and RS 67333, a partial agonist of 5-HT4 receptors, enhances place and object recognition in young adult and old rats. Prog. Neuropsychopharmacol. Biol. Psychiatry 27 (2003), 185–195.
185. Laruelle, M., Kegeles, L.S., Abi-Dargham, A., Glutamate dopamine, and schizophrenia: from pathophysiology to treatment. Ann. N. Y. Acad. Sci. 1003 (2003), 138–158.
186. Lecoutey, C., Hedou, D., Freret, T., Giannoni, P., Gaven, F., Since, M., Bouet, V., Ballandonne, C., Corvaisier, S., Malzert Fréon, A., et al. Design of donecopride, a dual serotonin subtype 4 receptor agonist/acetylcholinesterase inhibitor with potential interest for Alzheimerés disease treatment. Proc. Natl. Acad. Sci. 111 (2014), E3825–E3830.
187. Lee, T., Winter, C., Marticke, S.S., Lee, A., Luo, L., Essential roles of Drosophila RhoA in the regulation of neuroblast proliferation and dendritic but not axonal morphogenesis. Neuron 25 (2000), 307–316.
188. Lee, S., Hjerling-Leffler, J., Zagha, E., Fishell, G., Rudy, B., The largest group of superficial neocortical GABAergic interneurons expresses ionotropic serotonin receptors. J. Neurosci. 30 (2010), 16796–16808.
189. Lelong, V., Lhonneur, L., Dauphin, F., Boulouard, M., BIMU 1 and RS 67333, two 5-HT4 receptor agonists, modulate spontaneous alternation deficits induced by scopolamine in the mouse. Naunyn. Schmiedebergs Arch. Pharmacol. 367 (2003), 621–628.
190. Lemonde, S., Turecki, G., Bakish, D., Du, L., Hrdina, P.D., Bown, C.D., Sequeira, A., Kushwaha, N., Morris, S.J., Basak, A., et al. Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. J. Neurosci. Off. J. Soc. Neurosci. 23 (2003), 8788–8799.
191. Levitt, P., Rakic, P., The time of genesis: embryonic origin and differentiation of the brain stem monoamine neurons in the rhesus monkey. Brain Res. 256 (1982), 35–57.
192. Lezoualc'h, F., 5-HT4 receptor and Alzheimer's disease: the amyloid connection. Exp. Neurol. 205 (2007), 325–329.
193. Li, Z., Van Aelst, L., Cline, H.T., Rho GTPases regulate distinct aspects of dendritic arbor growth in Xenopus central neurons in vivo. Nat. Neurosci. 3 (2000), 217–225.
194. Li, Z., Aizenman, C.D., Cline, H.T., Regulation of rho GTPases by crosstalk and neuronal activity in vivo. Neuron 33 (2002), 741–750.
195. Lieske, V., Bennett-Clarke, C.A., Rhoades, R.W., Effects of serotonin on neurite outgrowth from thalamic neurons in vitro. Neuroscience 90 (1999), 967–974.
196. Lima, L., Matus, P., Urbina, M., Serotonin inhibits outgrowth of goldfish retina and impairs the trophic effect of taurine. J. Neurosci. Res. 38 (1994), 444–450.
197. Lin, S.L., Johnson-Farley, N.N., Lubinsky, D.R., Cowen, D.S., Coupling of neuronal 5-HT7 receptors to activation of extracellular-regulated kinase through a protein kinase A-independent pathway that can utilize Epac. J. Neurochem. 87 (2003), 1076–1085.
198. Linseman, D.A., Loucks, F.A., Diverse roles of Rho family GTPases in neuronal development, survival, and death. Front. Biosci. J. Virtual Libr. 13 (2008), 657–676.
199. Liu, J.P., Lauder, J.M., Serotonin and nialamide differentially regulate survival and growth of cultured serotonin and catecholamine neurons. Brain Res. Dev. Brain Res. 62 (1991), 297–305.
200. Lo, A.C., De Maeyer, J.H., Vermaercke, B., Callaerts-Vegh, Z., Schuurkes, J.A.J., D'Hooge, R., SSP-002392, a new 5-HT4 receptor agonist, Dose-dependently reverses scopolamine-induced learning and memory impairments in C57Bl/6 mice. Neuropharmacology 85 (2014), 178–189.
201. Locker, M., Bitard, J., Collet, C., Poliard, A., Mutel, V., Launay, J.M., Kellermann, O., Stepwise control of osteogenic differentiation by 5-HT2B receptor signaling: nitric oxide production and phospholipase A2 activation. Cell. Signal. 18 (2006), 628–639.
202. Lohmann, C., Wong, R.O.L., Regulation of dendritic growth and plasticity by local and global calcium dynamics. Cell Calcium 37 (2005), 403–409.
203. Lotto, B., Upton, L., Price, D.J., Gaspar, P., Serotonin receptor activation enhances neurite outgrowth of thalamic neurones in rodents. Neurosci. Lett. 269 (1999), 87–90.
204. Lovenberg, T.W., Baron, B.M., de Lecea, L., Miller, J.D., Prosser, R.A., Rea, M.A., Foye, P.E., Racke, M., Slone, A.L., Siegel, B.W., A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms. Neuron 11 (1993), 449–458.
205. Lucki, I., Behavioral studies of serotonin receptor agonists as antidepressant drugs. J. Clin. Psychiatry 52:Suppl (1991), 24–31.
206. Magariños, A.M., Verdugo, J.M., McEwen, B.S., Chronic stress alters synaptic terminal structure in hippocampus. Proc. Natl. Acad. Sci. U. S. A. 94 (1997), 14002–14008.
207. Manser, E., Leung, T., Salihuddin, H., Zhao, Z.S., Lim, L., A brain serine/threonine protein kinase activated by Cdc42 and Rac1. Nature 367 (1994), 40–46.
208. Manuel-Apolinar, L., Rocha, L., Pascoe, D., Castillo, E., Castillo, C., Meneses, A., Modifications of 5-HT4 receptor expression in rat brain during memory consolidation. Brain Res. 1042 (2005), 73–81.
209. Manzke, T., Guenther, U., Ponimaskin, E.G., Haller, M., Dutschmann, M., Schwarzacher, S., Richter, D.W., 5-HT4(a) receptors avert opioid-Induced Breathing depression without loss of analgesia. Science 301 (2003), 226–229.
210. Marsman, A., van den Heuvel, M.P., Klomp, D.W.J., Kahn, R.S., Luijten, P.R., Hulshoff Pol, H.E., Glutamate in schizophrenia: a focused review and meta-analysis of H-MRS studies. Schizophr. Bull. 39 (2013), 120–129.
211. Masson, J., Emerit, M.B., Hamon, M., Darmon, M., Serotonergic signaling: multiple effectors and pleiotropic effects. Wiley Interdiscip. Rev. Membr. Transp. Signal. 1 (2012), 685–713.
212. Matthys, A., Haegeman, G., Van Craenenbroeck, K., Vanhoenacker, P., Role of the 5-HT7 receptor in the central nervous system: from current status to future perspectives. Mol. Neurobiol. 43 (2011), 228–253.
213. Mazer, C., Muneyyirci, J., Taheny, K., Raio, N., Borella, A., Whitaker-Azmitia, P., Serotonin depletion during synaptogenesis leads to decreased synaptic density and learning deficits in the adult rat: a possible model of neurodevelopmental disorders with cognitive deficits. Brain Res. 760 (1997), 68–73.
214. Meffre, J., Chaumont-Dubel, S., Mannoury la Cour, C., Loiseau, F., Watson, D.J.G., Dekeyne, A., Séveno, M., Rivet, J.-M., Gaven, F., Déléris, P., et al. 5-HT6 receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia. EMBO Mol. Med. 4 (2012), 1043–1056.
215. Meller, R., Harrison, P.J., Elliott, J.M., Sharp, T., In vitro evidence that 5-hydroxytryptamine increases efflux of glial glutamate via 5-HT(2A) receptor activation. J. Neurosci. Res. 67 (2002), 399–405.
216. Meltzer, H.Y., The role of serotonin in antipsychotic drug action. Neuropsychopharmacology 21 (1999), 106S–115S.
217. Mendez, J., Kadia, T.M., Somayazula, R.K., El-Badawi, K.I., Cowen, D.S., Differential coupling of serotonin 5-HT1A and 5-HT1B receptors to activation of ERK2 and inhibition of adenylyl cyclase in transfected CHO cells. J. Neurochem. 73 (1999), 162–168.
218. Mendez-David, I., David, D.J., Darcet, F., Wu, M.V., Kerdine-Römer, S., Gardier, A.M., Hen, R., Rapid anxiolytic effects of a 5-HT4 receptor agonist are mediated by a neurogenesis-Independent mechanism. Neuropsychopharmacology 39 (2014), 1366–1378.
219. Meneses, A., Stimulation of 5-HT1A 5-HT1B, 5-HT2A/2C, 5-HT3 and 5-HT4 receptors or 5-HT uptake inhibition: short- and long-term memory. Behav. Brain Res. 184 (2007), 81–90.
220. Mercer, A.R., Kirchhof, B.S., Hildebrand, J.G., Enhancement by serotonin of the growth in vitro of antennal lobe neurons of the sphinx moth Manduca sexta. J. Neurobiol. 29 (1996), 49–64.
221. Millan, M.J., Marin, P., Bockaert, J., Mannoury la Cour, C., Signaling at G-protein-coupled serotonin receptors: recent advances and future research directions. Trends Pharmacol. Sci. 29 (2008), 454–464.
222. Millan, M.J., Improving the treatment of schizophrenia: focus on serotonin (5-HT)1A receptors. J. Pharmacol. Exp. Ther. 295 (2000), 853–861.
223. Millan, M.J., Serotonin 5-HT2C receptors as a target for the treatment of depressive and anxious states: focus on novel therapeutic strategies. Thérapie 60 (2005), 441–460.
224. Miquel, M.-C., Emerit, M.B., Nosjean, A., Simon, A., Rumajogee, P., Brisorgueil, M.-J., Doucet, E., Hamon, M., Vergé, D., Differential subcellular localization of the 5-HT3-As receptor subunit in the rat central nervous system. Eur. J. Neurosci. 15 (2002), 449–457.
225. Miyamoto, S., Miyake, N., Jarskog, L.F., Fleischhacker, W.W., Lieberman, J.A., Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents. Mol. Psychiatry 17 (2012), 1206–1227.
226. Mizutani, H., Hori, T., Takahashi, T., 5-HT1B receptor-mediated presynaptic inhibition at the calyx of Held of immature rats. Eur. J. Neurosci. 24 (2006), 1946–1954.
227. Mocci, G., Jiménez-Sánchez, L., Adell, A., Cortés, R., Artigas, F., Expression of 5-HT2A receptors in prefrontal cortex pyramidal neurons projecting to nucleus accumbens: potential relevance for atypical antipsychotic action. Neuropharmacology 79 (2014), 49–58.
228. Mogha, A., Guariglia, S.R., Debata, P.R., Wen, G.Y., Banerjee, P., Serotonin 1A receptor-mediated signaling through ERK and PKCα is essential for normal synaptogenesis in neonatal mouse hippocampus. Transl. Psychiatry, 2, 2012, e66.
229. Monsma, F.J., Shen, Y., Ward, R.P., Hamblin, M.W., Sibley, D.R., Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs. Mol. Pharmacol. 43 (1993), 320–327.
230. Morikawa, H., Manzoni, O.J., Crabbe, J.C., Williams, J.T., Regulation of central synaptic transmission by 5-HT(1B) Auto- and heteroreceptors. Mol. Pharmacol. 58 (2000), 1271–1278.
231. Muguruza, C., Miranda-Azpiazu, P., Díez-Alarcia, R., Morentin, B., González-Maeso, J., Callado, L.F., Meana, J.J., Evaluation of 5-HT2A and mGlu2/3 receptors in postmortem prefrontal cortex of subjects with major depressive disorder: effect of antidepressant treatment. Neuropharmacology 86 (2014), 311–318.
232. Mulherkar, S., Uddin, M.D., Couvillon, A.D., Sillitoe, R.V., Tolias, K.F., The small GTPases RhoA and Rac1 regulate cerebellar development by controlling cell morphogenesis migration and foliation. Dev. Biol. 394 (2014), 39–53.
233. Murthy, S., Niquille, M., Hurni, N., Limoni, G., Frazer, S., Chameau, P., van Hooft, J.A., Vitalis, T., Dayer, A., Serotonin receptor 3A controls interneuron migration into the neocortex. Nat. Commun., 5, 2014, 5524.
234. Myhrer, T., Neurotransmitter systems involved in learning and memory in the rat: a meta-analysis based on studies of four behavioral tasks. Brain Res. Rev. 41 (2003), 268–287.
235. Narboux-Nême, N., Angenard, G., Mosienko, V., Klempin, F., Pitychoutis, P.M., Deneris, E., Bader, M., Giros, B., Alenina, N., Gaspar, P., Postnatal growth defects in mice with constitutive depletion of central serotonin. ACS Chem. Neurosci. 4 (2012), 171–181.
236. Nebigil, C.G., Maroteaux, L., Functional consequence of serotonin/5-HT2B receptor signaling in heart role of mitochondria in transition between hypertrophy and heart failure?. Circulation 108 (2003), 902–908.
237. Nebigil, C.G., Etienne, N., Messaddeq, N., Maroteaux, L., Serotonin is a novel survival factor of cardiomyocytes: mitochondria as a target of 5-HT2B receptor signaling. FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol. 17 (2003), 1373–1375.
238. Nelson, D.L., 5-HT5 receptors. CNS Neurol. Disord. – Drug Targets Former. Curr. Drug Targets – CNS Neurol. Disord. 3 (2004), 53–58.
239. Newey, S.E., Velamoor, V., Govek, E.-E., Van Aelst, L., Rho GTPases, dendritic structure, and mental retardation. J. Neurobiol. 64 (2005), 58–74.
240. Nichols, D.E., Nichols, C.D., Serotonin receptors. Chem. Rev. 108 (2008), 1614–1641.
241. Niesler, B., Walstab, J., Combrink, S., Möller, D., Kapeller, J., Rietdorf, J., Bönisch, H., Göthert, M., Rappold, G., Brüss, M., Characterization of the novel human serotonin receptor subunits 5-HT3C,5-HT3D, and 5-HT3E. Mol. Pharmacol. 72 (2007), 8–17.
242. Niesler, B., 5-HT(3) receptors: potential of individual isoforms for personalised therapy. Curr. Opin. Pharmacol. 11 (2011), 81–86.
243. Nikiforuk, A., Popik, P., Amisulpride promotes cognitive flexibility in rats: the role of 5-HT7 receptors. Behav. Brain Res. 248 (2013), 136–140.
244. Nikiforuk, A., Selective blockade of 5-HT7 receptors facilitates attentional set-shifting in stressed and control rats. Behav. Brain Res. 226 (2012), 118–123.
245. Noda, M., Yasuda, S., Okada, M., Higashida, H., Shimada, A., Iwata, N., Ozaki, N., Nishikawa, K., Shirasawa, S., Uchida, M., et al. Recombinant human serotonin 5A receptors stably expressed in C6 glioma cells couple to multiple signal transduction pathways. J. Neurochem. 84 (2003), 222–232.
246. Norrholm, S.D., Ouimet, C.C., Chronic fluoxetine administration to juvenile rats prevents age-associated dendritic spine proliferation in hippocampus. Brain Res. 883 (2000), 205–215.
247. Numakawa, T., Suzuki, S., Kumamaru, E., Adachi, N., Richards, M., Kunugi, H., BDNF function and intracellular signaling in neurons. Histol. Histopathol. 25 (2010), 237–258.
248. Odajima, J., Wills, Z.P., Ndassa, Y.M., Terunuma, M., Kretschmannova, K., Deeb, T.Z., Geng, Y., Gawrzak, S., Quadros, I.M., Newman, J., et al. Cyclin e constrains cdk5 activity to regulate synaptic plasticity and memory formation. Dev. Cell 21 (2011), 655–668.
249. Oertner, T.G., Matus, A., Calcium regulation of actin dynamics in dendritic spines. Cell Calcium 37 (2005), 477–482.
250. Oliver, K.R., Kinsey, A.M., Wainwright, A., Sirinathsinghji, D.J.S., Localization of 5-ht5A receptor-like immunoreactivity in the rat brain. Brain Res. 867 (2000), 131–142.
251. Oostland, M., Sellmeijer, J., van Hooft, J.A., Transient expression of functional serotonin 5-HT3 receptors by glutamatergic granule cells in the early postnatal mouse cerebellum. J. Physiol. 589 (2011), 4837–4846.
252. Opal, M.D., Klenotich, S.C., Morais, M., Bessa, J., Winkle, J., Doukas, D., Kay, L.J., Sousa, N., Dulawa, S.M., Serotonin 2C receptor antagonists induce fast-onset antidepressant effects. Mol. Psychiatry 19 (2014), 1106–1114.
253. Pan, J., Li, H., Zhang, B., Xiong, R., Zhang, Y., Kang, W.-Y., Chen, W., Zhao, Z.-B., Chen, S.-D., Small peptide inhibitor of JNK3 protects dopaminergic neurons from MPTP induced injury via inhibiting the ASK1-JNK3 signaling pathway. PLoS One, 10, 2015, e0119204.
254. Parks, C.L., Robinson, P.S., Sibille, E., Shenk, T., Toth, M., Increased anxiety of mice lacking the serotonin1A receptor. Proc. Natl. Acad. Sci. U. S. A. 95 (1998), 10734–10739.
255. 4 receptor agonist RS67333. Int. J. Neuropsychopharmacol. Off. Sci. J. Coll. Int. Neuropsychopharmacol. CINP 15 (2012), 631–643.
256. Pasqualetti, M., Ori, M., Nardi, I., Castagna, M., Cassano, G.B., Marazziti, D., Distribution of the 5-HT5A serotonin receptor mRNA in the human brain. Brain Res. Mol. Brain Res. 56 (1998), 1–8.
257. Pazos, A., Palacios, J.M., Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors. Brain Res. 346 (1985), 205–230.
258. Pazos, A., Cortés, R., Palacios, J.M., Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors. Brain Res. 346 (1985), 231–249.
259. Penington, N.J., Kelly, J.S., Serotonin receptor activation reduces calcium current in an acutely dissociated adult central neuron. Neuron 4 (1990), 751–758.
260. Peroutka, S.J., Snyder, S.H., Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine: [3H]lysergic acid diethylamide and [3H]spiroperidol. Mol. Pharmacol. 16 (1979), 687–699.
261. Persico, A.M., Di Pino, G., Levitt, P., Multiple receptors mediate the trophic effects of serotonin on ventroposterior thalamic neurons in vitro. Brain Res. 1095 (2006), 17–25.
262. Pindon, A., van Hecke, G., van Gompel, P., Lesage, A.S., Leysen, J.E., Jurzak, M., Differences in signal transduction of two 5-HT4 receptor splice variants: compound specificity and dual coupling with Galphas- and Galphai/o-proteins. Mol. Pharmacol. 61 (2002), 85–96.
263. Piszczek, L., Piszczek, A., Kuczmanska, J., Audero, E., Gross, C.T., Modulation of anxiety by cortical serotonin 1A receptors. Front. Behav. Neurosci., 9, 2015.
264. Plassat, J.L., Boschert, U., Amlaiky, N., Hen, R., The mouse 5HT5 receptor reveals a remarkable heterogeneity within the 5HT1D receptor family. EMBO J. 11 (1992), 4779–4786.
265. Plassat, J.L., Amlaiky, N., Hen, R., Molecular cloning of a mammalian serotonin receptor that activates adenylate cyclase. Mol. Pharmacol. 44 (1993), 229–236.
266. Pompeiano, M., Palacios, J.M., Mengod, G., Distribution and cellular localization of mRNA coding for 5-HT1A receptor in the rat brain: correlation with receptor binding. J. Neurosci. Off. J. Soc. Neurosci. 12 (1992), 440–453.
267. Pompeiano, M., Palacios, J.M., Mengod, G., Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors. Brain Res. Mol. Brain Res. 23 (1994), 163–178.
268. Ponimaskin, E.G., Profirovic, J., Vaiskunaite, R., Richter, D.W., Voyno-Yasenetskaya, T.A., 5-Hydroxytryptamine 4(a) receptor is coupled to the G subunit of heterotrimeric G13 protein. J. Biol. Chem. 277 (2002), 20812–20819.
269. Ponimaskin, E., Voyno-Yasenetskaya, T., Richter, D.W., Schachner, M., Dityatev, A., Morphogenic signaling in neurons via neurotransmitter receptors and small GTPases. Mol. Neurobiol. 35 (2007), 278–287.
270. Prasad, M.V.V.S.V., Dermott, J.M., Heasley, L.E., Johnson, G.L., Dhanasekaran, N., Activation of jun kinase/Stress-activated protein kinase by GTPase-deficient mutants of Gα12 and Gα13. J. Biol. Chem. 270 (1995), 18655–18659.
271. Puthanveettil, S.V., Monje, F.J., Miniaci, M.C., Choi, Y.-B., Karl, K.A., Khandros, E., Gawinowicz, M.A., Sheetz, M.P., Kandel, E.R., A new component in synaptic plasticity: upregulation of kinesin in the neurons of the gill-Withdrawal reflex. Cell 135 (2008), 960–973.
272. Puzzo, D., Gulisano, W., Arancio, O., Palmeri, A., The keystone of Alzheimer pathogenesis might be sought in Aβ physiology. Neuroscience 307 (2015), 26–36.
273. Quiedeville, A., Boulouard, M., Hamidouche, K., Da Silva Costa-Aze, V., Nee, G., Rochais, C., Dallemagne, P., Fabis, F., Freret, T., Bouet, V., Chronic activation of 5-HT4 receptors or blockade of 5-HT6 receptors improve memory performances. Behav. Brain Res. 293 (2015), 10–17.
274. Quinn, J.C., Johnson-Farley, N.N., Yoon, J., Cowen, D.S., Activation of extracellular-regulated kinase by 5-hydroxytryptamine(2A) receptors in PC12 cells is protein kinase C-independent and requires calmodulin and tyrosine kinases. J. Pharmacol. Exp. Ther. 303 (2002), 746–752.
275. Rajasethupathy, P., Antonov, I., Sheridan, R., Frey, S., Sander, C., Tuschl, T., Kandel, E.R., A role for neuronal piRNAs in the epigenetic control of memory-Related synaptic plasticity. Cell 149 (2012), 693–707.
276. Ramakrishna, A., Giridhar, P., Ravishankar, G.A., Phytoserotonin. Plant Signal. Behav. 6 (2011), 800–809.
277. Rannikko, I., Haapea, M., Miettunen, J., Veijola, J., Murray, G.K., Barnett, J.H., Husa, A.P., Jones, P.B., Isohanni, M., Jääskeläinen, E., Changes in verbal learning and memory in schizophrenia and non-psychotic controls in midlife: a nine-year follow-up in the Northern Finland Birth Cohort study 1966. Psychiatry Res. 228 (2015), 671–679.
278. Rapport, M.M., Green, A.A., Page, I.H., Partial purification of the vasoconstrictor in beef serum. J. Biol. Chem. 174 (1948), 735–741.
279. Rapport, M.M., Green, A.A., Page, I.H., Serum vasoconstrictor: serotonin; isolation and characterization. J. Biol. Chem. 176 (1948), 1243–1251.
280. Rasbach, K.A., Funk, J.A., Jayavelu, T., Green, P.T., Schnellmann, R.G., 5-hydroxytryptamine receptor stimulation of mitochondrial biogenesis. J. Pharmacol. Exp. Ther. 332 (2010), 632–639.
281. Rees, S., den Daas, I., Foord, S., Goodson, S., Bull, D., Kilpatrick, G., Lee, M., Cloning and characterisation of the human 5-HT5A serotonin receptor. FEBS Lett. 355 (1994), 242–246.
282. Rehnström, K., Ylisaukko-oja, T., Nummela, I., Ellonen, P., Kempas, E., Vanhala, R., von Wendt, L., Järvelä, I., Peltonen, L., Allelic variants in HTR3C show association with autism. Am. J. Med. Genet. Part B Neuropsychiatr. Genet. Off. Publ. Int. Soc. Psychiatr. Genet. 150B (2009), 741–746.
283. Renner, U., Zeug, A., Woehler, A., Niebert, M., Dityatev, A., Dityateva, G., Gorinski, N., Guseva, D., Abdel-Galil, D., Fröhlich, M., et al. Heterodimerization of serotonin receptors 5-HT1A and 5-HT7 differentially regulates receptor signalling and trafficking. J. Cell Sci. 125 (2012), 2486–2499.
284. Restivo, L., Roman, F., Dumuis, A., Bockaert, J., Marchetti, E., Ammassari-Teule, M., The promnesic effect of G-protein-coupled 5-HT4 receptors activation is mediated by a potentiation of learning-induced spine growth in the mouse hippocampus. Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol. 33 (2008), 2427–2434.
285. Riad, M., Garcia, S., Watkins, K.C., Jodoin, N., Doucet, E., Langlois, X., el Mestikawy, S., Hamon, M., Descarries, L., Somatodendritic localization of 5-HT1A and preterminal axonal localization of 5-HT1B serotonin receptors in adult rat brain. J. Comp. Neurol. 417 (2000), 181–194.
286. Riccio, O., Potter, G., Walzer, C., Vallet, P., Szabó, G., Vutskits, L., Kiss, J.Z., Dayer, A.G., Excess of serotonin affects embryonic interneuron migration through activation of the serotonin receptor 6. Mol. Psychiatry 14 (2008), 280–290.
287. Richardson-Jones, J.W., Craige, C.P., Nguyen, T.H., Kung, H.F., Gardier, A.M., Dranovsky, A., David, D.J., Guiard, B.P., Beck, S.G., Hen, R., et al. Serotonin-1A autoreceptors are necessary and sufficient for the normal formation of circuits underlying innate anxiety. J. Neurosci. Off. J. Soc. Neurosci. 31 (2011), 6008–6018.
288. Richter, D.W., Manzke, T., Wilken, B., Ponimaskin, E., Serotonin receptors: guardians of stable breathing. Trends Mol. Med. 9 (2003), 542–548.
289. Rojas, P.S., Neira, D., Muñoz, M., Lavandero, S., Fiedler, J.L., Serotonin (5-HT) regulates neurite outgrowth through 5-HT1A and 5-HT7 receptors in cultured hippocampal neurons. J. Neurosci. Res. 92 (2014), 1000–1009.
290. Roth, B.L., Hanizavareh, S.M., Blum, A.E., Serotonin receptors represent highly favorable molecular targets for cognitive enhancement in schizophrenia and other disorders. Psychopharmacology (Berl.) 174 (2004), 17–24.
291. Ruat, M., Traiffort, E., Leurs, R., Tardivel-Lacombe, J., Diaz, J., Arrang, J.M., Schwartz, J.C., Molecular cloning characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation. Proc. Natl. Acad. Sci. U. S. A. 90 (1993), 8547–8551.
292. Ruat, M., Traiffort, E., Arrang, J.M., Tardivellacombe, J., Diaz, J., Leurs, R., Schwartz, J.C., A novel rat serotonin (5-HT6) receptor: molecular cloning: localization and stimulation of cAMP accumulation. Biochem. Biophys. Res. Commun. 193 (1993), 268–276.
293. Salichon, N., Gaspar, P., Upton, A.L., Picaud, S., Hanoun, N., Hamon, M., Maeyer, E.D., Murphy, D.L., Mössner, R., Lesch, K.P., et al. Excessive activation of serotonin (5-HT) 1B receptors disrupts the formation of sensory maps in monoamine oxidase a and 5-HT transporter knock-Out mice. J. Neurosci. 21 (2001), 884–896.
294. Sanchez, S., Sayas, C.L., Lim, F., Diaz-Nido, J., Avila, J., Wandosell, F., The inhibition of phosphatidylinositol-3-kinase induces neurite retraction and activates GSK3. J. Neurochem. 78 (2001), 468–481.
295. Sanders-Bush, E., Breeding, M., Putative selective 5-HT-2 antagonists block serotonin 5-HT-1c receptors in the choroid plexus. J. Pharmacol. Exp. Ther. 247 (1988), 169–173.
296. Sanno, H., Shen, X., Kuru, N., Bormuth, I., Bobsin, K., Gardner, H.A.R., Komljenovic, D., Tarabykin, V., Erzurumlu, R.S., Tucker, K.L., Control of postnatal apoptosis in the neocortex by RhoA-subfamily GTPases determines neuronal density. J. Neurosci. Off. J. Soc. Neurosci. 30 (2010), 4221–4231.
297. Santini, M.A., Ratner, C., Aznar, S., Klein, A.B., Knudsen, G.M., Mikkelsen, J.D., Enhanced prefrontal serotonin 2A receptor signaling in the subchronic phencyclidine mouse model of schizophrenia. J. Neurosci. Res. 91 (2013), 634–641.
298. Sargent, P.A., Kjaer, K.H., Bench, C.J., Rabiner, E.A., Messa, C., Meyer, J., Gunn, R.N., Grasby, P.M., Cowen, P.J., Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment. Arch. Gen. Psychiatry 57 (2000), 174–180.
299. Sari, Y., Miquel, M.-C., Brisorgueil, M.-J., Ruiz, G., Doucet, E., Hamon, M., Vergé, D., Cellular and subcellular localization of 5-hydroxytryptamine1B receptors in the rat central nervous system: immunocytochemical, autoradiographic and lesion studies. Neuroscience 88 (1999), 899–915.
300. Sarina, Yagi, Y., Nakano, O., Hashimoto, T., Kimura, K., Asakawa, Y., Zhong, M., Narimatsu, S., Gohda, E., Induction of neurite outgrowth in PC12 cells by artemisinin through activation of ERK and p38 MAPK signaling pathways. Brain Res. 1490 (2013), 61–71.
301. Schmeisser, M.J., Baumann, B., Johannsen, S., Vindedal, G.F., Jensen, V., Hvalby, Ø.C., Sprengel, R., Seither, J., Maqbool, A., Magnutzki, A., et al. IκB kinase/nuclear factor κB-dependent insulin-like growth factor 2 (Igf2) expression regulates synapse formation and spine maturation via Igf2 receptor signaling. J. Neurosci. Off. J. Soc. Neurosci. 32 (2012), 5688–5703.
302. Schmidt, U., Pilgrim, C., Beyer, C., Differentiative effects of dopamine on striatal neurons involve stimulation of the cAMP/PKA pathway. Mol. Cell. Neurosci 11 (1998), 9–18.
303. Schratt, G.M., Nigh, E.A., Chen, W.G., Hu, L., Greenberg, M.E., BDNF regulates the translation of a select group of mRNAs by a mammalian target of rapamycin-Phosphatidylinositol 3-Kinase-Dependent pathway during neuronal development. J. Neurosci. 24 (2004), 7366–7377.
304. Schwartz, K., Yadid, G., Weizman, A., Rehavi, M., Decreased limbic vesicular monoamine transporter 2 in a genetic rat model of depression. Brain Res. 965 (2003), 174–179.
305. Schwieger, J., Warnecke, A., Lenarz, T., Esser, K.-H., Scheper, V., Neuronal survival, morphology and outgrowth of spiral ganglion neurons using a defined growth factor combination. PLoS One, 10, 2015, e0133680.
306. Sebök, A., Nusser, N., Debreceni, B., Guo, Z., Santos, M.F., Szeberenyi, J., Tigyi, G., Different roles for RhoA during neurite initiation, elongation, and regeneration in PC12 cells. J. Neurochem. 73 (1999), 949–960.
307. Semenova, M.M., Mäki-Hokkonen, A.M.J., Cao, J., Komarovski, V., Forsberg, K.M., Koistinaho, M., Coffey, E.T., Courtney, M.J., Rho mediates calcium-dependent activation of p38alpha and subsequent excitotoxic cell death. Nat. Neurosci. 10 (2007), 436–443.
308. Severin, E.S., Kondratyev, A.D., Regulation of differentiation of PC12 cells by nerve growth factor. Adv. Enzyme Regul. 27 (1988), 357–370.
309. Shen, Y., Monsma, F.J., Metcalf, M.A., Jose, P.A., Hamblin, M.W., Sibley, D.R., Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype. J. Biol. Chem. 268 (1993), 18200–18204.
310. Shenker, A., Maayani, S., Weinstein, H., Green, J.P., Pharmacological characterization of two 5-hydroxytryptamine receptors coupled to adenylate cyclase in guinea pig hippocampal membranes. Mol. Pharmacol. 31 (1987), 357–367.
311. Sheu, F.S., Azmitia, E.C., Marshak, D.R., Parker, P.J., Routtenberg, A., Glial-derived S100b protein selectively inhibits recombinant beta protein kinase C (PKC) phosphorylation of neuron-specific protein F1/GAP43. Brain Res. Mol. Brain Res. 21 (1994), 62–66.
312. Shi, J., Damjanoska, K.J., Zemaitaitis, B., Garcia, F., Carrasco, G., Sullivan, N.R., She, Y., Young, K.H., Battaglia, G., Van De kar, L.D., et al. Alterations in 5-HT2A receptor signaling in male and female transgenic rats over-expressing either Gq or RGS-insensitive Gq protein. Neuropharmacology 51 (2006), 524–535.
313. Shirayama, Y., Chaki, S., Neurochemistry of the nucleus accumbens and its relevance to depression and antidepressant action in rodents. Curr. Neuropharmacol. 4 (2006), 277–291.
314. Sikich, L., Hickok, J.M., Todd, R.D., 5-HT1A receptors control neurite branching during development. Brain Res. Dev. Brain Res. 56 (1990), 269–274.
315. Smit-Rigter, L.A., Wadman, W.J., van Hooft, J.A., Impaired social behavior in 5-HT(3A) receptor knockout mice. Front. Behav. Neurosci., 4, 2010, 169.
316. Smit-Rigter, L.A., Wadman, W.J., van Hooft, J.A., Alterations in apical dendrite bundling in the somatosensory cortex of 5-HT(3A) receptor knockout mice. Front. Neuroanat., 5, 2011, 64.
317. 3 receptor-dependent cortical abnormalities and anxiety-like behaviour. Neuropharmacology 62 (2012), 865–870.
318. Solem, M., McMahon, T., Messing, R.O., Depolarization-induced neurite outgrowth in PC12 cells requires permissive, low level NGF receptor stimulation and activation of calcium/calmodulin-dependent protein kinase. J. Neurosci. 15 (1995), 5966–5975.
319. Sotelo, C., Cholley, B., El Mestikawy, S., Gozlan, H., Hamon, M., Direct immunohistochemical evidence of the existence of 5-HT1A autoreceptors on serotoninergic neurons in the midbrain raphe nuclei. Eur. J. Neurosci. 2 (1990), 1144–1154.
320. Soumier, A., Banasr, M., Lortet, S., Masmejean, F., Bernard, N., Kerkerian-Le-Goff, L., Gabriel, C., Millan, M.J., Mocaer, E., Daszuta, A., Mechanisms contributing to the phase-dependent regulation of neurogenesis by the novel antidepressant agomelatine, in the adult rat hippocampus. Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol. 34 (2009), 2390–2403.
321. Speranza, L., Chambery, A., Di Domenico, M., Crispino, M., Severino, V., Volpicelli, F., Leopoldo, M., Bellenchi, G.C., di Porzio, U., Perrone-Capano, C., The serotonin receptor 7 promotes neurite outgrowth via ERK and Cdk5 signaling pathways. Neuropharmacology 67 (2013), 155–167.
322. Speranza, L., Giuliano, T., Volpicelli, F., De Stefano, M.E., Lombardi, L., Chambery, A., Lacivita, E., Leopoldo, M., Bellenchi, G.C., di Porzio, U., et al. Activation of 5-HT7 receptor stimulates neurite elongation through mTOR, Cdc42 and actin filaments dynamics. Front. Behav. Neurosci., 9, 2015.
323. Stankiewicz, T.R., Linseman, D.A., Rho family GTPases: key players in neuronal development, neuronal survival, and neurodegeneration. Front. Cell. Neurosci., 8, 2014, 314.
324. Sumiyoshi, T., Park, S., Jayathilake, K., Roy, A., Ertugrul, A., Meltzer, H.Y., Effect of buspirone a serotonin1A partial agonist, on cognitive function in schizophrenia: a randomized, double-blind, placebo-controlled study. Schizophr. Res. 95 (2007), 158–168.
325. Sun, H., Hu, X.-Q., Emerit, M.B., Schoenebeck, J.C., Kimmel, C.E., Peoples, R.W., Miko, A., Zhang, L., Modulation of 5-HT3 receptor desensitization by the light chain of microtubule-associated protein 1B expressed in HEK 293 cells. J. Physiol. 586 (2008), 751–762.
326. Takeda, K., Hatai, T., Hamazaki, T.S., Nishitoh, H., Saitoh, M., Ichijo, H., Apoptosis signal-regulating kinase 1 (ASK1) induces neuronal differentiation and survival of PC12 cells. J. Biol. Chem. 275 (2000), 9805–9813.
327. Tamburella, A., Micale, V., Navarria, A., Drago, F., Antidepressant properties of the 5-HT4 receptor partial agonist: sL65.0155: behavioral and neurochemical studies in rats. Prog. Neuropsychopharmacol. Biol. Psychiatry 33 (2009), 1205–1210.
328. Tanaka, T., Serneo, F.F., Tseng, H.-C., Kulkarni, A.B., Tsai, L.-H., Gleeson, J.G., Cdk5 phosphorylation of doublecortin ser297 regulates its effect on neuronal migration. Neuron 41 (2004), 215–227.
329. Tang, G., Dong, X., Huang, X., Huang, X.-J., Liu, H., Wang, Y., Ye, W.-C., Shi, L., A natural diarylheptanoid promotes neuronal differentiation via activating ERK and PI3K-Akt dependent pathways. Neuroscience 303 (2015), 389–401.
330. Tao, X., Finkbeiner, S., Arnold, D.B., Shaywitz, A.J., Greenberg, M.E., Ca2+ influx regulates BDNF transcription by a CREB family transcription factor-Dependent mechanism. Neuron 20 (1998), 709–726.
331. Tavazoie, S.F., Alvarez, V.A., Ridenour, D.A., Kwiatkowski, D.J., Sabatini, B.L., Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2. Nat. Neurosci. 8 (2005), 1727–1734.
332. Tecott, L.H., Sun, L.M., Akana, S.F., Strack, A.M., Lowenstein, D.H., Dallman, M.F., Julius, D., Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors. Nature 374 (1995), 542–546.
333. Thomas, D.R., Hagan, J.J., 5-HT7 receptors. Curr. Drug Targets CNS Neurol. Disord. 3 (2004), 81–90.
334. Thomas, D.R., Soffin, E.M., Roberts, C., Kew, J.N.C., de la Flor, R.M., Dawson, L.A., Fry, V.A., Coggon, S.A., Faedo, S., Hayes, P.D., et al. SB-699551-A (3-cyclopentyl-N-[2-(dimethylamino)ethyl]-N-[(4′-{[(2-phenylethyl)amino]methyl}-4-biphenylyl)methyl]propanamide dihydrochloride), a novel 5-ht5A receptor-selective antagonist, enhances 5-HT neuronal function: evidence for an autoreceptor role for the 5-ht5A receptor in guinea pig brain. Neuropharmacology 51 (2006), 566–577.
335. Thompson, A.J., Lummis, S.C., The 5-HT3 receptor as a therapeutic target. Expert Opin. Ther. Targets 11 (2007), 527–540.
336. Toth, M., 5-HT1A receptor knockout mouse as a genetic model of anxiety. Eur. J. Pharmacol. 463 (2003), 177–184.
337. Turlejski, K., Evolutionary ancient roles of serotonin: long-lasting regulation of activity and development. Acta Neurobiol. Exp. (Warsz.) 56 (1996), 619–636.
338. Turner, T.J., Mokler, D.J., Luebke, J.I., Calcium influx through presynaptic 5-HT3 receptors facilitates GABA release in the hippocampus: in vitro slice and synaptosome studies. Neuroscience 129 (2004), 703–718.
339. Twarog, B.M., Page, I.H., Serotonin content of some mammalian tissues and urine and a method for its determination. Am. J. Physiol. 175 (1953), 157–161.
340. Twarog, B.M., Responses of a molluscan smooth muscle to acetylcholine and 5-hydroxytryptamine. J. Cell. Comp. Physiol. 44 (1954), 141–163.
341. Udo, H., Jin, I., Kim, J.-H., Li, H.-L., Youn, T., Hawkins, R.D., Kandel, E.R., Bailey, C.H., Serotonin-Induced regulation of the actin network for learning-Related synaptic growth requires cdc42, N-WASP, and PAK in aplysia sensory neurons. Neuron 45 (2005), 887–901.
342. Vázquez-Borsetti, P., Cortés, R., Artigas, F., Pyramidal neurons in rat prefrontal cortex projecting to ventral tegmental area and dorsal raphe nucleus express 5-HT2A receptors. Cereb. Cortex N. Y. N 1991:19 (2009), 1678–1686.
343. Vaidya, V.A., Marek, G.J., Aghajanian, G.K., Duman, R.S., 5-HT2A receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex. J. Neurosci. Off. J. Soc. Neurosci. 17 (1997), 2785–2795.
344. van der Velden, L., Hooft, J.A., van Chameau, P., Altered dendritic complexity affects firing properties of cortical layer 2/3 pyramidal neurons in mice lacking the 5-HT3A receptor. J. Neurophysiol. 108 (2012), 1521–1528.
345. Vialli, M., Erspamer, V., Ricerche sul secreto delle cellule enterocromaffini: nota VII Osservazioni critiche su alcuni problemi inerenti alla istochimica delle enterocromaffini. Z. Für Zellforsch. Mikrosk. Anat. 27 (1937), 81–99.
346. Vilaró, M.T., Cortés, R., Mengod, G., Serotonin 5-HT4 receptors and their mRNAs in rat and guinea pig brain: distribution and effects of neurotoxic lesions. J. Comp. Neurol. 484 (2005), 418–439.
347. Vitalis, T., Parnavelas, J.G., The role of serotonin in early cortical development. Dev. Neurosci. 25 (2003), 245–256.
348. Vitalis, T., Cases, O., Passemard, S., Callebert, J., Parnavelas, J.G., Embryonic depletion of serotonin affects cortical development. Eur. J. Neurosci. 26 (2007), 331–344.
349. Voigt, M.M., Laurie, D.J., Seeburg, P.H., Bach, A., Molecular cloning and characterization of a rat brain cDNA encoding a 5-hydroxytryptamine1B receptor. EMBO J. 10 (1991), 4017–4023.
350. Volk, B., Nagy, B.J., Vas, S., Kostyalik, D., Simig, G., Bagdy, G., Medicinal chemistry of 5-HT5A receptor ligands: a receptor subtype with unique therapeutical potential. Curr. Top. Med. Chem. 10 (2010), 554–578.
351. Vollenweider, F.X., Vollenweider-Scherpenhuyzen, M.F., Bäbler, A., Vogel, H., Hell, D., Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action. Neuroreport 9 (1998), 3897–3902.
352. Waeber, C., Sebben, M., Nieoullon, A., Bockaert, J., Dumuis, A., Regional distribution and ontogeny of 5-HT4 binding sites in rodent brain. Neuropharmacology 33 (1994), 527–541.
353. Wang, L., Lv, Y., Deng, W., Peng, X., Xiao, Z., Xi, Z., Chen, G., Wang, X., 5-HT6 receptor recruitment of mTOR modulates seizure activity in epilepsy. Mol. Neurobiol. 51 (2015), 1292–1299.
354. Wawra, M., Fidzinski, P., Heinemann, U., Mody, I., Behr, J., 5-HT4-Receptors modulate induction of long-Term depression but not potentiation at hippocampal output synapses in acute rat brain slices. PLoS One, 9, 2014.
355. Weisskopf, M.G., Castillo, P.E., Zalutsky, R.A., Nicoll, R.A., Mediation of hippocampal mossy fiber long-term potentiation by cyclic AMP. Science 265 (1994), 1878–1882.
356. Welsh, J.H., Taub, R., The action of acetylcholine antagonists on the heart of venus mercenaria*. Br. J. Pharmacol. Chemother. 8 (1953), 327–333.
357. Wesołowska, A., Nikiforuk, A., Stachowicz, K., Tatarczyńska, E., Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression. Neuropharmacology 51 (2006), 578–586.
358. Wesołowska, A., In the search for selective ligands of 5-HT5, 5-HT6 and 5-HT7 serotonin receptors. Pol. J. Pharmacol. 54 (2002), 327–341.
359. Wesołowska, A., Nikiforuk, A., Stachowicz, K.1, Potential anxiolytic and antidepressant effects of the selective 5-HT7 receptor antagonist SB 269970 after intrahippocampal administration to rats. Eur. J. Pharmacol. 553 (2006), 185–190.
360. West, P.J., Marcy, V.R., Marino, M.J., Schaffhauser, H., Activation of the 5-HT6 receptor attenuates long-term potentiation and facilitates GABAergic neurotransmission in rat hippocampus. Neuroscience 164 (2009), 692–701.
361. Whitaker-Azmitia, P.M., Murphy, R., Azmitia, E.C., Stimulation of astroglial 5-HT1A receptors releases the serotonergic growth factor protein S-100, and alters astroglial morphology. Brain Res. 528 (1990), 155–158.
362. Whitaker-Azmitia, P.M., Wingate, M., Borella, A., Gerlai, R., Roder, J., Azmitia, E.C., Transgenic mice overexpressing the neurotrophic factor S-100 beta show neuronal cytoskeletal and behavioral signs of altered aging processes: implications for Alzheimer's disease and Down's syndrome. Brain Res. 776 (1997), 51–60.
363. Wisden, W., Parker, E.M., Mahle, C.D., Grisel, D.A., Nowak, H.P., Yocca, F.D., Felder, C.C., Seeburg, P.H., Voigt, M.M., Cloning and characterization of the rat 5-HT5B receptor: evidence that the 5-HT5B receptor couples to a G protein in mammalian cell membranes. FEBS Lett. 333 (1993), 25–31.
364. Witkin, J.M., Baez, M., Yu, J., Barton, M.E., Shannon, H.E., Constitutive deletion of the serotonin-7 (5-HT7) receptor decreases electrical and chemical seizure thresholds. Epilepsy Res. 75 (2007), 39–45.
365. Wouters, M.M., Roeder, J.L., Tharayil, V.S., Stanich, J.E., Strege, P.R., Lei, S., Bardsley, M.R., Ordog, T., Gibbons, S.J., Farrugia, G., Protein kinase C{gamma} mediates regulation of proliferation by the serotonin 5-hydroxytryptamine receptor 2B. J. Biol. Chem. 284 (2009), 21177–21184.
366. Wu, H., Lu, D., Jiang, H., Xiong, Y., Qu, C., Li, B., Mahmood, A., Zhou, D., Chopp, M., Simvastatin-mediated upregulation of VEGF and BDNF, activation of the PI3K/Akt pathway, and increase of neurogenesis are associated with therapeutic improvement after traumatic brain injury. J. Neurotrauma 25 (2008), 130–139.
367. Xie, Z., Sanada, K., Samuels, B.A., Shih, H., Tsai, L.-H., Serine 732 phosphorylation of FAK by cdk5 is important for microtubule organization, nuclear movement, and neuronal migration. Cell 114 (2003), 469–482.
368. Xu, N., Engbers, J., Khaja, S., Xu, L., Clark, J.J., Hansen, M.R., Influence of cAMP and protein kinase A on neurite length from spiral ganglion neurons. Hear. Res. 283 (2012), 33–44.
369. Yamazaki, M., Harada, K., Yamamoto, N., Yarimizu, J., Okabe, M., Shimada, T., Ni, K., Matsuoka, N., ASP5736 a novel 5-HT5A receptor antagonist, ameliorates positive symptoms and cognitive impairment in animal models of schizophrenia. Eur. Neuropsychopharmacol. J. Eur. Coll. Neuropsychopharmacol. 24 (2014), 1698–1708.
370. Yin, N., Hong, X., Han, Y., Duan, Y., Zhang, Y., Chen, Z., Cortex Mori Radicis Extract induces neurite outgrowth in PC12 cells activating ERK signaling pathway via inhibiting Ca(2+) influx. Int. J. Clin. Exp. Med. 8 (2015), 5022–5032.
371. Yoshioka, M., Matsumoto, M., Togashi, H., Mori, K., Central distribution and function of 5-ht6 receptor subtype in the rat brain. Ann. N. Y. Acad. Sci., 861, 1998, 244.
372. Yuan, X., Jin, M., Xu, X., Song, Y., Wu, C., Poo, M., Duan, S., Signalling and crosstalk of Rho GTPases in mediating axon guidance. Nat. Cell Biol. 5 (2003), 38–45.
373. Yun, H.-M., Baik, J.-H., Kang, I., Jin, C., Rhim, H., Physical interaction of jab1 with human serotonin 6 G-protein-coupled receptor and their possible roles in cell survival. J. Biol. Chem. 285 (2010), 10016–10029.
374. Zanassi, P., Paolillo, M., Feliciello, A., Avvedimento, E.V., Gallo, V., Schinelli, S., cAMP-dependent protein kinase induces cAMP-response element-binding protein phosphorylation via an intracellular calcium release/ERK-dependent pathway in striatal neurons. J. Biol. Chem. 276 (2001), 11487–11495.
375. Zhang, Y., Gu, X., Yuan, X., Phenylalanine activates the mitochondria-mediated apoptosis through the RhoA/Rho-associated kinase pathway in cortical neurons. Eur. J. Neurosci. 25 (2007), 1341–1348.
376. Zhang, Q., Zhu, Y., Zhou, W., Gao, L., Yuan, L., Han, X., Serotonin receptor 2C and insulin secretion. PLoS One, 8, 2013, e54250.
377. Zhang, L., Fang, Y., Xu, Y., Lian, Y., Xie, N., Wu, T., Zhang, H., Sun, L., Zhang, R., Wang, Z., Curcumin improves amyloid β-Peptide (1–42) induced spatial memory deficits through BDNF-ERK signaling pathway. PLoS One, 10, 2015, e0131525.
378. Zheng, J.Q., Poo, M.-M., Calcium signaling in neuronal motility. Annu. Rev. Cell Dev. Biol. 23 (2007), 375–404.
379. Zhu, H., Wu, F., Schacher, S., Aplysia cell adhesion molecules and serotonin regulate sensory cell- motor cell interactions during early stages of synapse formation in vitro. J. Neurosci. 14 (1994), 6886–6900.
380. de Foubert, G., O'Neill, M.J., Zetterström, T.S.C., Acute onset by 5-HT(6)-receptor activation on rat brain-derived neurotrophic factor and activity-regulated cytoskeletal-associated protein mRNA expression. Neuroscience 147 (2007), 778–785.